Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-26

Clinical Trial Update: Cefixime for Alternative Syphilis Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cefixime as an alternative treatment for early syphilis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFIXIME (cefixime)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Syphilis, Early Syphilis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-26